Drug
Wegovy ®
Wegovy ® is a pharmaceutical drug with 4 clinical trials. Currently 2 active trials ongoing.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
2(50%)
Phase Distribution
Ph phase_1
1
25%
Ph phase_3
3
75%
Phase Distribution
1
Early Stage
0
Mid Stage
3
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 3Large-scale testing
3(75.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
4
all time
Status Distribution
Active(4)
Detailed Status
Not yet recruiting2
Recruiting2
Development Timeline
Analytics
Development Status
Total Trials
4
Active
2
Success Rate
N/A
Most Advanced
Phase 3
Trials by Phase
Phase 11 (25.0%)
Phase 33 (75.0%)
Trials by Status
not_yet_recruiting250%
recruiting250%
Recent Activity
2 active trials
Showing 4 of 4
not_yet_recruitingphase_3
Semaglutide in Patients Undergoing Transcatether Aortic Valve Replacement
NCT07090343
recruitingphase_3
Efficacy and Safety of Semaglutide Injection Vs WEGOVY® in Chinese Obese Patients
NCT07036172
recruitingphase_1
The Safety, Tolerability, and Pharmacokinetics of of SYH9017 in Chinese Participants With Overweight and Obesity
NCT06830343
not_yet_recruitingphase_3
A Clinical Study Comparing Semaglutide Injection and Wegovy® for Weight Management in Obese Subjects
NCT06738979
Clinical Trials (4)
Showing 4 of 4 trials
NCT07090343Phase 3
Semaglutide in Patients Undergoing Transcatether Aortic Valve Replacement
NCT07036172Phase 3
Efficacy and Safety of Semaglutide Injection Vs WEGOVY® in Chinese Obese Patients
NCT06830343Phase 1
The Safety, Tolerability, and Pharmacokinetics of of SYH9017 in Chinese Participants With Overweight and Obesity
NCT06738979Phase 3
A Clinical Study Comparing Semaglutide Injection and Wegovy® for Weight Management in Obese Subjects
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4